Search results for "viruses"

showing 10 items of 1182 documents

ID: 37

2015

During the early phase of human cytomegalovirus (HCMV) infection, the Interferon- γ -Inducible factor 16 (IFI16) behaves as a pattern recognition receptor (PRR) sensing viral DNA and triggering antiviral cytokine release. Later on, it restricts virus replication by down-regulating expression of viral genes committed to DNA synthesis including UL54 and UL44. These activities are modulated by viral proteins including pUL83, a tegument protein involved in viral evasion. Here, we demonstrate that pUL83 interacts with IFI16 relieving its inhibitory activity on UL54 gene transcription. We also establish that, starting from 48 h post-infection, IFI16 is stabilized and protected from degradation by…

Human cytomegalovirusDNA synthesisIFI16virusesImmunologyMutantHematologyBiologymedicine.diseaseBiochemistryMolecular biologyViral replicationInterferonGene expressionmedicineProteasome inhibitorImmunology and AllergyMolecular Biologymedicine.drugCytokine
researchProduct

The Complex Regulatory Role of Cytomegalovirus Nuclear Egress Protein pUL50 in the Production of Infectious Virus

2021

The regulation of the nucleocytoplasmic release of herpesviral capsids is defined by the process of nuclear egress. Due to their large size, nuclear capsids are unable to traverse via nuclear pores, so that herpesviruses evolved to develop a vesicular transport pathway mediating their transition through both leaflets of the nuclear membrane. This process involves regulatory proteins, which support the local distortion of the nuclear envelope. For human cytomegalovirus (HCMV), the nuclear egress complex (NEC) is determined by the pUL50-pUL53 core that initiates multicomponent assembly with NEC-associated proteins and capsids. Hereby, pUL50 serves as a multi-interacting determinant that recru…

Human cytomegalovirusGene Expression Regulation ViralProteomicsefficiency of infectious virus productionQH301-705.5Nuclear Envelope[SDV]Life Sciences [q-bio]virusesQuantitative proteomicsCytomegalovirusconditional expressionGenome Viralnuclear egress complex (NEC)Virus ReplicationArticleCell LineViral ProteinsCapsidNEC protein pUL50DNA PackagingmedicineHumansddc:610Biology (General)Nuclear poreNuclear membraneregulation of viral replicationGenes Immediate-EarlyCell Nucleusfunctional propertiesChemistryVirionGeneral MedicineFibroblastsmedicine.diseaseCell biologyVesicular transport protein[SDV] Life Sciences [q-bio]Kineticsmedicine.anatomical_structureLytic cycleCapsidhuman cytomegalovirusLamin
researchProduct

Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with…

2010

The tegument protein pp65 of human cytomegalovirus (HCMV) is abundant in lytically infected human foreskin fibroblasts (HFF), as well as in virions and subviral dense bodies (DB). Despite this, we showed previously that pp65 is dispensable for growth in HFF. In the process of refining a DB-based vaccine candidate, different HCMV mutants were generated, expressing a dominant HLA-A2-presented peptide of the IE1 protein fused to pp65. One of the mutant viruses (RV-VM1) surprisingly showed marked impairment in virus release from HFF. We hypothesized that analysis of the phenotypic alterations of RV-VM1 would provide insight into the functions of pp65, poorly defined thus far. RV-VM1 infection r…

Human cytomegalovirusImmunoprecipitationvirusesMutantCytomegalovirusBiologyVirus ReplicationVirusInclusion bodiesViral Matrix ProteinsViral ProteinsVirologymedicineHumansImmunoprecipitationCells Culturedvirus diseasesRNAViral tegumentFibroblastsPhosphoproteinsmedicine.diseaseVirologyFusion proteinTrans-ActivatorsProtein MultimerizationProtein BindingJournal of General Virology
researchProduct

Impact of infectious burden on extent and long-term prognosis of atherosclerosis.

2002

Background — Recent findings suggest a causative role of infections in the pathogenesis of atherosclerosis. In hypothesizing an association between infectious agents and the development of atherosclerosis, we would expect a correlation to the extent of atherosclerosis. Moreover, this effect could be multiplied by the number of pathogens to which an individual had been exposed. Methods and Results — In 572 patients, IgG or IgA antibodies to herpes simplex virus 1 and 2, cytomegalovirus, Epstein-Barr virus, Hemophilus influenzae , Chlamydia pneumoniae , Mycoplasma pneumoniae , and Helicobacter pylori were measured. The extent of atherosclerosis was determined by coronary angiography, carotid…

Human cytomegalovirusMalemedicine.medical_specialtyHerpesvirus 4 HumanTime FactorsArteriosclerosisCarotid arteriesCytomegalovirusCoronary diseasemedicine.disease_causeAntibodies ViralHerpesviridaePathogenesisRisk FactorsPhysiology (medical)medicineHumansSimplexvirusIntensive care medicineAgedHelicobacter pyloribusiness.industryBacterial InfectionsChlamydophila pneumoniaeMiddle Agedmedicine.diseasePrognosisAntibodies BacterialHaemophilus influenzaeSurvival AnalysisDNA Virus InfectionsImmunoglobulin AMycoplasma pneumoniaeSurvival RateC-Reactive ProteinLogistic ModelsHerpesvirus hominisImmunoglobulin GImmunologyMultivariate AnalysisVirusesFemaleCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

The immunogenicity of human and murine cytomegaloviruses.

2000

Cytomegaloviruses are strictly host-species-specific. During an aeon of co-evolution, virus and host have found an arrangement: the productive and cytopathogenic cycle of viral gene expression is held in check by the host's immune response. As a consequence, cytomegalovirus disease is restricted to the immunocompromised host. The virus has evolved strategies to avoid its elimination and eventually hides itself in a silent state, referred to as 'viral latency'. Redundant molecular mechanisms have been identified by which cytomegaloviruses interfere with antigen presentation pathways to 'evade' immune control. In the annual period covered by this review, the IE1 protein was revisited as an im…

Human cytomegalovirusMuromegalovirusvirusesImmunologyAntigen presentationCongenital cytomegalovirus infectionCytomegalovirusImmunodominanceBiologyVirusImmediate early proteinImmediate-Early ProteinsViral Matrix ProteinsMiceViral ProteinsAntigenmedicineImmunology and AllergyAnimalsHumansAntigen PresentationImmunogenicityHistocompatibility Antigens Class IIvirus diseasesReceptors Antigen T-Cell gamma-deltamedicine.diseasePhosphoproteinsVirologyKiller Cells NaturalImmunologyCurrent opinion in immunology
researchProduct

Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining

1993

Chronic villitis is almost always present in intrauterine infection with human cytomegalovirus (HCMV). The inflammatory response to this virus has been described in detail. However, little is known about the types of placental cells that may be infected by HCMV and six cases of HCMV placentitis were thus investigated to identify the vulnerable cell types. Immunohistochemical double staining analyses were performed using antibodies to HCMV immediate early antigens and to specific cellular marker proteins. Fixed connective tissue cells could be demonstrated to be the predominantly infected cell type in each placental tissue. Endothelial cells and macrophages were also found to be infected in …

Human cytomegalovirusPathologymedicine.medical_specialtyPlacenta DiseasesTransplacental transmissionvirusesCongenital cytomegalovirus infectionCytomegalovirusConnective tissuePathology and Forensic MedicineAntigenPregnancymedicineHumansVimentinMacrophageEndotheliumPregnancy Complications InfectiousAntigens ViralMolecular BiologyCytopathic effectbiologyMacrophagesvirus diseasesCell BiologyGeneral Medicinemedicine.diseaseImmunohistochemistryVirologymedicine.anatomical_structureConnective TissueCytomegalovirus Infectionsbiology.proteinFemaleAntibodyVirchows Archiv A Pathological Anatomy and Histopathology
researchProduct

Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations

2003

Human cytomegalovirus (HCMV) strains, obtained from immunocompetent and immunocompromised Italian hosts, were typed with glycoprotein B (gB) gene restriction analysis. A predominant circulation of HCMV strains with gB type 2 and 3 was detected in both the immunocompetent host with a primary HCMV infection and the immunocompromised host with or without HCMV disease. No association between gB types and subjects with different risks of developing HCMV disease was found. All four gB genotypes were capable of causing congenital infection in Italian babies, with gB type 1 accounting for 50% of the strains examined in symptomatic infants and a remarkable incidence of gB type 4 viruses.

Human cytomegalovirusSettore MED/07 - Microbiologia E Microbiologia Clinicamedicine.medical_specialtyGenotypevirusesRestriction MappingCongenital cytomegalovirus infectionCytomegalovirusHIV Infectionsmedicine.disease_causePolymerase Chain ReactionHerpesviridaeVirusImmunocompromised HostMedical microbiologyViral Envelope ProteinsBetaherpesvirinaeVirologyGenotypemedicineHumansBone Marrow TransplantationbiologyInfant Newbornvirus diseasesGeneral Medicinebiology.organism_classificationmedicine.diseaseKidney TransplantationVirologyHuman cytomegalovirus immunocompromised gB genotypes ItalyCytomegalovirus InfectionsViral diseaseImmunocompetenceArchives of Virology
researchProduct

Adoptive Transfer of T-Cell-Receptor Engineered Human T Cells Specifically Reduces Viral Titers in HLA-Transgenic NSG Mice Infected with a Humanized …

2014

Abstract Reactivation of latent human cytomegalovirus (HCMV) infection is a frequent complication in patients after allogeneic hematopoietic stem cell transplantation (HSCT). Preclinical research in murine models as well as clinical phase I/II trials have shown that the adoptive transfer of virus-specific CD8+ T cells is a therapeutic option for preventing HCMV disease. However, the feasibility of HCMV-specific immunotherapy is currently limited in clinical routine due to technical restrictions. It has also limitations, if the donor is HCMV-seronegative or carries only low numbers of HCMV-specific memory T cells. In this situation, grafting non-reactive T cells by virus-antigen specific T-c…

Human cytomegalovirusSevere combined immunodeficiencyAdoptive cell transfervirusesT cellmedicine.medical_treatmentImmunologyCell BiologyHematologyImmunotherapyBiologymedicine.diseaseBiochemistryVirologyCell therapymedicine.anatomical_structureImmune systemImmunologymedicineCD8Blood
researchProduct

Proteomic Analyses of Human Cytomegalovirus Strain AD169 Derivatives Reveal Highly Conserved Patterns of Viral and Cellular Proteins in Infected Fibr…

2014

Human cytomegalovirus (HCMV) particle morphogenesis in infected cells is an orchestrated process that eventually results in the release of enveloped virions. Proteomic analysis has been employed to reveal the complexity in the protein composition of these extracellular particles. Only limited information is however available regarding the proteome of infected cells preceding the release of HCMV virions. We used quantitative mass spectrometry to address the pattern of viral and cellular proteins in cells, infected with derivatives of the AD169 laboratory strain. Our analyses revealed a remarkable conservation in the patterns of viral and of abundant cellular proteins in cells, infected for 2…

Human cytomegalovirusTime FactorsProteomeviruseslcsh:QR1-502MorphogenesisCytomegalovirusBiologyVirus ReplicationProteomicslcsh:MicrobiologyMass SpectrometryArticleCell LineproteomicsVirologyExtracellularmedicineHumanshuman cytomegalovirus; proteomics; mass spectrometry; virions; expression patternProteinsViral tegumentFibroblastsmedicine.diseaseVirologyCell biologyInfectious DiseasesViral replicationhuman cytomegalovirusCell cultureexpression patternHost-Pathogen InteractionsProteomevirionsViruses
researchProduct

Inhibition of CD1 antigen presentation by human cytomegalovirus.

2008

ABSTRACTThe betaherpesvirus human cytomegalovirus (HCMV) encodes several molecules that block antigen presentation by the major histocompatibility complex (MHC) proteins. Humans also possess one other family of antigen-presenting molecules, the CD1 family; however, the effect of HCMV on CD1 expression is unknown. The majority of CD1 molecules are classified on the basis of homology as group 1 CD1 and are present almost exclusively on professional antigen-presenting cells such as dendritic cells, which are a major target for HCMV infection and latency. We have determined that HCMV encodes multiple blocking strategies targeting group 1 CD1 molecules. CD1 transcription is strongly inhibited by…

Human cytomegalovirusTranscription GeneticvirusesImmunologyAntigen presentationCD1Cytomegaloviruschemical and pharmacologic phenomenaMajor histocompatibility complexmedicine.disease_causeMicrobiologycomplex mixturesCell LineAntigens CD1Immune systemAntigenVirologyMHC class ImedicineHumansCells CulturedAntigen PresentationbiologyImmunityhemic and immune systemsmedicine.diseaseVirologyProtein TransportHerpes simplex virusGene Expression RegulationInsect Sciencebiology.proteinPathogenesis and Immunitylipids (amino acids peptides and proteins)Journal of virology
researchProduct